| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $719.0M | +8.6% |
| Cost of Revenue | $74.6M | -4.3% |
| R&D Expense | $106.2M | -2.4% |
| SG&A Expense | $485.6M | +51.0% |
| Operating Income | -$62.3M | -176.3% |
| Interest Expense | $0 | — |
| Pre-tax Income | -$49.0M | -150.1% |
| Income Tax | -$10.5M | -143.7% |
| Net Income | -$38.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.4M | +85.3% |
| Accounts Receivable | $187.8M | +32.2% |
| Inventory | $112.5M | +107.2% |
| Current Assets | $644.2M | -6.1% |
| Total Assets | $1.45B | +6.2% |
| Current Liabilities | $338.2M | +15.7% |
| Total Liabilities | $390.9M | +17.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $47.3M | -72.5% |
| Capital Expenditures | $1.3M | +84.6% |
| Investing Cash Flow | $4.1M | +102.2% |
| Financing Cash Flow | $9.1M | -25.1% |
| Free Cash Flow | $46.0M | -73.1% |
| -152.2% |
| EPS (Basic) | -$0.68 | -150.7% |
| EPS (Diluted) | -$0.68 | -151.5% |
| Stockholders' Equity |
| $1.06B |
| +2.5% |